Regional outbreak of community-associated methicillin-resistant Staphylococcus aureus ST834 in Japanese children.
Anti-Bacterial Agents
/ pharmacology
Child
Cohort Studies
Community-Acquired Infections
/ epidemiology
Disease Outbreaks
/ statistics & numerical data
Humans
Japan
/ epidemiology
Methicillin-Resistant Staphylococcus aureus
/ drug effects
Microbial Sensitivity Tests
Staphylococcal Infections
/ epidemiology
Community-associated methicillin-resistant Staphylococcus aureus
Pediatrics
Purulent lymphadenitis
Regional outbreak
SaPISaitama2
Sequence type 834
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
09 Jan 2019
09 Jan 2019
Historique:
received:
15
09
2018
accepted:
20
12
2018
entrez:
11
1
2019
pubmed:
11
1
2019
medline:
6
2
2019
Statut:
epublish
Résumé
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection has recently become a challenging problem worldwide and in Japan. We experienced 10 pediatric patients infected with CA-MRSA and hospitalized from 2011 to 2014 in a tertiary care hospital in Saitama, Japan, and assessed the characteristic of the strains using a whole genome sequencing (WGS)-based approach. CA-MRSA strains isolated from infected patients who required hospitalization for treatment were evaluated in this study. Antimicrobial susceptibility tests, molecular typing by PCR and pulse-field gel electrophoresis (PFGE) were performed to characterize MRSA strains. WGS was performed for detailed genetic analysis. A total of 582 MRSA strains (35.2%) were identified among 1625 S. aureus strains collected during the study period. Ten MRSA strains (1.7%) were defined as CA-MRSA clinically, and all were isolated from pediatric patients. All strains mainly caused purulent lymphadenitis, were susceptible to fluoroquinolone and tetracycline, exhibited sequence type (ST) 834 or its single-locus variants and contained staphylococcal cassette chromosome mec (SCCmec) type IVc. Phylogenic analysis by PFGE and WGS revealed close relatedness of all strains, with the number of single nucleotide polymorphisms ranging from 35 to 119 by WGS. Out of the ten strains, nine possessed the genomic island SaPISaitama2 containing tst, sec and sel genes. SaPISaitama2 comprises a mosaic of genomic islands SaPIm4 and SaPIm1 harbored by a hospital-associated MRSA strain Mu50. This study describes a regional outbreak of ST834-related CA-MRSA in children with a unique pathogenicity island in Japan. Pediatric patient tropism of this clone could be enhanced by susceptibility to fluoroquinolones and tetracyclines, which cannot be prescribed to children.
Sections du résumé
BACKGROUND
BACKGROUND
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection has recently become a challenging problem worldwide and in Japan. We experienced 10 pediatric patients infected with CA-MRSA and hospitalized from 2011 to 2014 in a tertiary care hospital in Saitama, Japan, and assessed the characteristic of the strains using a whole genome sequencing (WGS)-based approach.
METHODS
METHODS
CA-MRSA strains isolated from infected patients who required hospitalization for treatment were evaluated in this study. Antimicrobial susceptibility tests, molecular typing by PCR and pulse-field gel electrophoresis (PFGE) were performed to characterize MRSA strains. WGS was performed for detailed genetic analysis.
RESULTS
RESULTS
A total of 582 MRSA strains (35.2%) were identified among 1625 S. aureus strains collected during the study period. Ten MRSA strains (1.7%) were defined as CA-MRSA clinically, and all were isolated from pediatric patients. All strains mainly caused purulent lymphadenitis, were susceptible to fluoroquinolone and tetracycline, exhibited sequence type (ST) 834 or its single-locus variants and contained staphylococcal cassette chromosome mec (SCCmec) type IVc. Phylogenic analysis by PFGE and WGS revealed close relatedness of all strains, with the number of single nucleotide polymorphisms ranging from 35 to 119 by WGS. Out of the ten strains, nine possessed the genomic island SaPISaitama2 containing tst, sec and sel genes. SaPISaitama2 comprises a mosaic of genomic islands SaPIm4 and SaPIm1 harbored by a hospital-associated MRSA strain Mu50.
CONCLUSIONS
CONCLUSIONS
This study describes a regional outbreak of ST834-related CA-MRSA in children with a unique pathogenicity island in Japan. Pediatric patient tropism of this clone could be enhanced by susceptibility to fluoroquinolones and tetracyclines, which cannot be prescribed to children.
Identifiants
pubmed: 30626342
doi: 10.1186/s12879-018-3646-z
pii: 10.1186/s12879-018-3646-z
pmc: PMC6327381
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
35Subventions
Organisme : Ministry of Education, Culture, Sports, Science and Technology (JP)
ID : S1201013
Organisme : St. Luke's Life Science Institute (JP)
ID : 2015-Research #27
Références
J Clin Microbiol. 1999 Oct;37(10):3411-4
pubmed: 10488222
Bioinformatics. 2000 Nov;16(11):1046-7
pubmed: 11159318
Lancet. 2001 Apr 21;357(9264):1225-40
pubmed: 11418146
JAMA. 2003 Dec 10;290(22):2976-84
pubmed: 14665659
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W273-9
pubmed: 15215394
J Clin Microbiol. 2005 Jul;43(7):3364-72
pubmed: 16000461
Emerg Infect Dis. 2006 Apr;12(4):631-7
pubmed: 16704812
Antimicrob Agents Chemother. 2007 Jan;51(1):264-74
pubmed: 17043114
Lancet Infect Dis. 2006 Dec;6(12):753-5
pubmed: 17123892
J Microbiol. 2007 Oct;45(5):447-52
pubmed: 17978805
BMC Genomics. 2008 Feb 08;9:75
pubmed: 18261238
J Antimicrob Chemother. 2008 Aug;62(2):324-8
pubmed: 18467309
J Clin Microbiol. 2008 Oct;46(10):3246-58
pubmed: 18685010
J Antimicrob Chemother. 2009 Oct;64(4):680-3
pubmed: 19684078
J Clin Microbiol. 2009 Dec;47(12):4138-40
pubmed: 19812280
J Infect Chemother. 2010 Aug;16(4):292-7
pubmed: 20306108
J Infect Chemother. 2010 Aug;16(4):225-54
pubmed: 20336341
Clin Microbiol Rev. 2010 Jul;23(3):616-87
pubmed: 20610826
Ann Clin Microbiol Antimicrob. 2010 Nov 04;9:31
pubmed: 21050425
Am J Trop Med Hyg. 2011 Feb;84(2):313-7
pubmed: 21292906
Am J Infect Control. 2011 Dec;39(10):858-65
pubmed: 21658811
Int J Pediatr. 2011;2011:143872
pubmed: 22187567
J Clin Microbiol. 2012 Mar;50(3):573-9
pubmed: 22205805
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
J Infect Chemother. 2012 Apr;18(2):228-40
pubmed: 22350401
PLoS One. 2012;7(2):e31245
pubmed: 22363594
N Engl J Med. 2012 Jun 14;366(24):2267-75
pubmed: 22693998
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
BMC Microbiol. 2012 Jul 23;12:146
pubmed: 22823982
BMC Genomics. 2012 Sep 25;13:508
pubmed: 23009684
Lancet Infect Dis. 2013 Feb;13(2):130-6
pubmed: 23158674
BMC Infect Dis. 2013 May 11;13:214
pubmed: 23663295
APMIS. 2014 Jul;122(7):580-4
pubmed: 24106794
Infect Chemother. 2013 Jun;45(2):117-36
pubmed: 24265961
Nucleic Acids Res. 2014 Jan;42(Database issue):D206-14
pubmed: 24293654
J Clin Microbiol. 2014 May;52(5):1501-10
pubmed: 24574290
PLoS One. 2014 Aug 11;9(8):e104984
pubmed: 25110940
J Clin Microbiol. 2014 Dec;52(12):4305-8
pubmed: 25297335
MBio. 2015 Mar 10;6(2):e00054
pubmed: 25759497
Microb Drug Resist. 2015 Aug;21(4):441-7
pubmed: 25789579
J Infect Chemother. 2015 Sep;21(9):700-2
pubmed: 26091885
Genome Announc. 2015 Nov 12;3(6):null
pubmed: 26564052
J Antimicrob Chemother. 2018 Jan 1;73(1):33-40
pubmed: 29048488
J Clin Microbiol. 1995 Sep;33(9):2233-9
pubmed: 7494007
J Clin Microbiol. 1998 Sep;36(9):2548-53
pubmed: 9705390